Videos are now available for the May VBPS event on Detection and Mitigation of Immunogenicity from Peptide Therapeutics.
On May 22nd, Daniela Verthelyi (Chief of the Immunology Lab in the Office of Pharmaceutical Quality Research, CDER, FDA) and Brian Roberts (Director of Preclinical Immunology, EpiVax, Inc.) each presented the strategies they are using to detect and mitigate immunogenicity of peptide therapeutics and related impurities.
Recordings of the seminar are available at www.boulderpeptide.org/virtual-bps/. *Please note - you must be logged in to the Boulder Peptide website to access the link*
If your company is interested in supporting future virtual symposia or other educational initiatives, please email sponsorship@boulderpeptide.org.